Literature DB >> 2994923

Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. II. Secondary CMV infections associated with impaired in vitro proliferative responses to mitogens, allogeneic lymphocytes and CMV infected cells.

H W Roenhorst, J M Beelen, J M Middeldorp, J Schirm, A M Tegzess, T H The.   

Abstract

The relationship between secondary cytomegalovirus (CMV) infections and host general cellular immunocompetence was investigated in 16 renal allograft recipients with minimal immunosuppressive treatment and excellent renal function. Results were compared with 19 CMV seropositive healthy controls. Significantly impaired immune responses were detected in the subgroup of nine recipients who experience at least 2 years before a secondary CMV infection. Their in vitro lymphocyte reactivity (LR) tests to phytohaemagglutinin (PHA, P = 0.01), pokeweed mitogen (PWM, P less than 0.05), microbial antigens (P less than 0.001) and to pooled allogeneic stimulator lymphocytes in the MLC test (P = 0.02) were lower than the controls. The MLC responses, however, increased with graft survival time (r = 0.8810, P = 0.01). This was positively correlated with the virus specific cellular immunity measurable by the LR responses to CMV infected target cells (r = 0.8333, P = 0.02). In contrast, long term renal allograft survivors who maintained their CMV infection in latency after transplantation (n = 7) showed normal responses to PWM, pooled lymphocytes and CMV infected target cells, whereas the responses to PHA and to bacterial antigens were less severely impaired (P less than 0.05 and P less than 0.001, respectively). This study of long term renal allograft survivors shows that a secondary CMV infection has a long lasting negative effect on immunity especially against alloantigens and CMV infected targets. However, in the data presented here it would be as acceptable to suggest that the patients are consistently relapsing with CMV because they initially had poor immune response and not vice versa.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994923      PMCID: PMC1577246     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Patterns of immune response in well tolerated renal grafts.

Authors:  E Renna; M Pelle; C Nesci; D Alfani; R Cortesini
Journal:  Transplant Proc       Date:  1978-09       Impact factor: 1.066

2.  Clinical manifestations of renal allograft derived primary cytomegalovirus infection.

Authors:  R F Betts; R B Freeman; R G Douglas; T E Talley
Journal:  Am J Dis Child       Date:  1977-07

3.  Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients.

Authors:  R H Rubin; A B Cosimi; N E Tolkoff-Rubin; P S Russell; M S Hirsch
Journal:  Transplantation       Date:  1977-12       Impact factor: 4.939

4.  Assessment of the status of cell-mediated immunity in cytomegalovirus-infected renal allograft recipients.

Authors:  M W Rytel; F G Aguilar-Torres; J Balay; L R Heim
Journal:  Cell Immunol       Date:  1978-04       Impact factor: 4.868

5.  Cellular immune response to cytomegalovirus infection after renal transplantation.

Authors:  C C Linnemann; C A Kauffman; M R First; G M Schiff; J P Phair
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

6.  Blastogenic response to mitogens: an approach to the study of cell-surface topography in lymphocytes from transplant recipients.

Authors:  K H Stenzel; A L Rubin; A Novogrodsky
Journal:  Transplant Proc       Date:  1978-09       Impact factor: 1.066

7.  Infection of adult mouse macrophages in vitro with cytomegalovirus.

Authors:  P J Tegtmeyer; J E Craighead
Journal:  Proc Soc Exp Biol Med       Date:  1968-12

8.  Epidemiology of cytomegalovirus infection after transplantation and immunosuppression.

Authors:  M Fiala; J E Payne; T V Berne; T C Moore; W Henle; J Z Montgomerie; S N Chatterjee; L B Guze
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

9.  Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation.

Authors:  R T Schooley; M S Hirsch; R B Colvin; A B Cosimi; N E Tolkoff-Rubin; R T McCluskey; R C Burton; P S Russell; J T Herrin; F L Delmonico; J V Giorgi; W Henle; R H Rubin
Journal:  N Engl J Med       Date:  1983-02-10       Impact factor: 91.245

10.  Depletion of lymphocytes with membrane markers of helper phenotype: a feature of acute and chronic drug-induced immunosuppression.

Authors:  E Dupont; L Schandene; R Devos; M Lambermont; J Wybran
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

View more
  1 in total

1.  The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts: development and maintenance of CMV-latency and its influence on immunocompetence.

Authors:  H W Roenhorst; C G Kallenberg; T H The
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.